WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q3 2016$6,126,000
+969.1%
49,211
+813.2%
0.02%
+1050.0%
Q2 2016$573,000
-97.7%
5,389
-97.5%
0.00%
-97.9%
Q1 2016$24,585,000
-37.3%
214,753
-22.0%
0.10%
-39.0%
Q4 2015$39,238,000
+326.8%
275,435
+169.1%
0.16%
+736.8%
Q3 2015$9,193,000102,3450.02%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2016
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders